These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34564891)
1. Topical metformin suppresses angiogenesis pathways induced by pulsed dye laser irradiation in animal models. Wang M; Lin Y; Shi W; Chen X; Mi Z; Jia Z; Pan Q; Wang Z; Han J; Liu H Exp Dermatol; 2022 Mar; 31(3):393-397. PubMed ID: 34564891 [TBL] [Abstract][Full Text] [Related]
2. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Tan W; Jia W; Sun V; Mihm MC; Nelson JS Lasers Surg Med; 2012 Dec; 44(10):796-804. PubMed ID: 23213008 [TBL] [Abstract][Full Text] [Related]
3. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment. Griffin TD; Foshee JP; Finney R; Saedi N Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090 [TBL] [Abstract][Full Text] [Related]
4. Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways. Gao L; Phan S; Nadora DM; Chernova M; Sun V; Preciado SM; Ballew B; Jia Z; Jia W; Wang G; Mihm MC; Nelson JS; Tan W Lasers Surg Med; 2014 Nov; 46(9):679-88. PubMed ID: 25270513 [TBL] [Abstract][Full Text] [Related]
5. Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. Gao L; Nadora DM; Phan S; Chernova M; Sun V; Preciado SM; Jia W; Wang G; Mihm MC; Nelson JS; Tan W Br J Dermatol; 2015 Mar; 172(3):669-76. PubMed ID: 25283693 [TBL] [Abstract][Full Text] [Related]
6. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial. Greveling K; Prens EP; van Doorn MB Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685 [TBL] [Abstract][Full Text] [Related]
7. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Chang CJ; Hsiao YC; Mihm MC; Nelson JS Lasers Surg Med; 2008 Nov; 40(9):605-10. PubMed ID: 18951427 [TBL] [Abstract][Full Text] [Related]
8. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Jia W; Sun V; Tran N; Choi B; Liu SW; Mihm MC; Phung TL; Nelson JS Lasers Surg Med; 2010 Feb; 42(2):105-12. PubMed ID: 20166161 [TBL] [Abstract][Full Text] [Related]
9. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application. Artzi O; Mehrabi JN; Heyman L; Friedman O; Mashiah J Dermatol Ther; 2020 Jan; 33(1):e13172. PubMed ID: 31747115 [TBL] [Abstract][Full Text] [Related]
10. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation. Doh EJ; Ohn J; Kim MJ; Kim YG; Cho S J Dermatolog Treat; 2017 Nov; 28(7):672-677. PubMed ID: 28285560 [TBL] [Abstract][Full Text] [Related]
11. Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature. Lipner SR Dermatol Surg; 2018 Jun; 44(6):796-802. PubMed ID: 29799824 [TBL] [Abstract][Full Text] [Related]
12. Pulsed dye laser and adjuvant topical therapies for the treatment of port-wine stains: A systematic review. Chou M; Karim M; Josephs J; Itzkowitz T; Dreker MR; Labadie JG Lasers Surg Med; 2024 Jan; 56(1):39-44. PubMed ID: 37431532 [TBL] [Abstract][Full Text] [Related]
13. Initial research on the effect and mechanism of Tivozanib on pulsed dye laser induced angiogenesis. Wang B; Zhang Y; Lou Y; Hu X; Li F Lasers Surg Med; 2022 Oct; 54(8):1157-1166. PubMed ID: 35916102 [TBL] [Abstract][Full Text] [Related]
14. Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. Loewe R; Oble DA; Valero T; Zukerberg L; Mihm MC; Nelson JS J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):76-82. PubMed ID: 20482679 [TBL] [Abstract][Full Text] [Related]
15. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone. Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993 [TBL] [Abstract][Full Text] [Related]
16. Why do port-wine stains (PWS) on the lateral face respond better to pulsed dye laser (PDL) than those located on the central face? Yu W; Ma G; Qiu Y; Chen H; Jin Y; Yang X; Hu X; Wang T; Chang L; Zhou H; Li W; Lin X J Am Acad Dermatol; 2016 Mar; 74(3):527-35. PubMed ID: 26892654 [TBL] [Abstract][Full Text] [Related]
17. EMLA cream does not influence efficacy and pain reduction during pulsed-dye laser treatment of port-wine stain: a prospective side-by-side comparison. Yu W; Wang T; Zhu J; Qiu Y; Chen H; Jin Y; Yang X; Hu X; Chang L; Chen Y; Ma G; Lin X Lasers Med Sci; 2018 Apr; 33(3):573-579. PubMed ID: 29247433 [TBL] [Abstract][Full Text] [Related]
18. Topical application of 5-aminolevulinic acid followed by 595-nm pulsed dye laser irradiation for the treatment of recalcitrant port-wine stains: a primary study. Liu S; Yang C; Yang S; Wang Z; Luo D; Zhang X J Cosmet Laser Ther; 2012 Aug; 14(4):189-92. PubMed ID: 22658236 [TBL] [Abstract][Full Text] [Related]
19. Side-by-side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks. Gao K; Huang Z; Yuan KH; Zhang B; Hu ZQ Br J Dermatol; 2013 May; 168(5):1040-6. PubMed ID: 23137063 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial. Fallahi M; Hallaji Z; Tavakolpour S; Niknam S; Salehi Farid A; Nili A; Teimourpour A; Daneshpazhooh M; Rahmati J; Haddady Abianeh S; Mahmoudi H J Cosmet Dermatol; 2021 Aug; 20(8):2498-2506. PubMed ID: 33251650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]